We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Invesco S&P 500 Pure Value ETF
RPV
$1.66B
| $584K | 0.01% |
+6,232
| New | +$560K |
|
1152
Abeona Therapeutics
ABEO
$355M
| $581K | 0.01% |
+102,336
| New | +$583K |
|
1153
LoveSac
LOVE
$242M
| $581K | 0.01% |
+31,924
| New | +$606K |
|
1154
Clear Channel Outdoor Holdings
CCO
$1.22B
| $579K | 0.01% |
+495,173
| New | +$535K |
|
1155
Atkore
ATKR
$2.41B
| $579K | 0.01% |
+8,209
| New | +$532K |
|
|
GMS
1156
DELISTED
GMS Inc
GMS
| $578K | 0.01% |
+5,317
| New | +$411K |
|
1157
Arcturus Therapeutics
ARCT
$165M
| $578K | 0.01% |
44,432
+21,355
| +93% | +$253K |
|
1158
Teekay
TK
$996M
| $577K | 0.01% |
+69,956
| New | +$542K |
|
1159
Schwab Fundamental US Small Company Index ETF
FNDA
$9.1B
| $577K | 0.01% |
+20,141
| New | +$546K |
|
1160
News Corp Class A
NWSA
$15.6B
| $577K | 0.01% |
+19,404
| New | +$533K |
|
1161
Ameresco
AMRC
$980M
| $575K | 0.01% |
+37,866
| New | +$496K |
|
1162
Cirrus Logic
CRUS
$6.76B
| $575K | 0.01% |
+5,516
| New | +$540K |
|
1163
Ingredion
INGR
$6.42B
| $572K | 0.01% |
+4,218
| New | +$570K |
|
1164
LXP Industrial Trust
LXP
$3.52B
| $572K | 0.01% |
+13,847
| New | +$570K |
|
1165
Bank OZK
OZK
$5.63B
| $568K | 0.01% |
12,074
-13,638
| -53% | -$597K |
|
|
SOBO
1166
South Bow Corp
SOBO
$7.79B
| $565K | 0.01% |
21,809
+7,159
| +49% | +$182K |
|
|
KREF
1167
KKR Real Estate Finance Trust
KREF
$466M
| $564K | 0.01% |
64,279
+19,354
| +43% | +$178K |
|
1168
InterContinental Hotels
IHG
$23.8B
| $564K | 0.01% |
+4,887
| New | +$548K |
|
|
ONC
1169
BeOne Medicines Ltd
ONC
$33.9B
| $564K | 0.01% |
+2,328
| New | +$571K |
|
1170
Fastly Inc
FSLY
$3.24B
| $557K | 0.01% |
+78,960
| New | +$529K |
|
1171
Cheniere Energy
LNG
$54.2B
| $557K | 0.01% |
2,287
-2,791
| -55% | -$646K |
|
1172
Build-A-Bear
BBW
$445M
| $555K | 0.01% |
+10,772
| New | +$456K |
|
1173
Myriad Genetics
MYGN
$476M
| $552K | 0.01% |
104,002
-8,982
| -8% | -$53.1K |
|
1174
Vodafone
VOD
$37.1B
| $552K | 0.01% |
51,741
+2,397
| +5% | +$23.2K |
|
1175
Global X MLP & Energy Infrastructure ETF
MLPX
$3.58B
| $547K | 0.01% |
8,733
+4,959
| +131% | +$301K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.